Biopsychosocial Model of Irritable Bowel Syndrome

被引:217
作者
Tanaka, Yukari [1 ]
Kanazawa, Motoyori [1 ]
Fukudo, Shin [1 ]
Drossman, Douglas A. [2 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 9808575, Japan
[2] Univ N Carolina, Ctr Funct GI & Motil Disorders, Chapel Hill, NC USA
关键词
Irritable bowel syndrome; Pathophysiology; Psychology; FUNCTIONAL GASTROINTESTINAL DISORDERS; COGNITIVE-BEHAVIORAL THERAPY; ABDOMINAL-PAIN; PSYCHOSOCIAL-ASPECTS; PHYSICAL ABUSE; BRAIN; ILLNESS; IMPACT; ASSOCIATION; PLACEBO;
D O I
10.5056/jnm.2011.17.2.131
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Irritable bowel syndrome (IBS) is a common chronic disorder seen in gastroenterology and primary care practice. It is characterized by recurrent abdominal pain or discomfort associated with disturbed bowel function. It is a heterogeneous disorder with varying treatments, and in this regard physicians sometimes struggle with finding the optimal approach to management of patients with IBS. This disorder induces high health care costs and variably reduces health-related quality of life. IBS is in the class of functional gastrointestinal disorders, and results from dysregulation of central and enteric nervous system interactions. Psychosocial factors are closely related to their gut physiology, associated cognitions, symptom manifestations and illness behavior. Therefore, it is important for the physician to recognize the psychosocial issues of patients with IBS and in addition to build a good patient-physician relationship in order to optimize treatment. This review focuses on the interaction between psychological and physiological factors associated with IBS by using a biopsychosocial model. In this article, we describe (1) the predisposing psychological features seen in early life; (2) the psychological factors associated with life stress, the symptom presentation, and their associated coping patterns; (3) gut pathophysiology with emphasis on disturbances in motility, visceral hypersensitivity and brain-gut interactions; and finally (4) the clinical outcomes and effective treatments including psychotherapeutic methods.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 83 条
[1]
Length of Office Visits for Gastrointestinal Disease: Impact of Physician Specialty [J].
Ananthakrishnan, Ashwin N. ;
McGinley, Emily L. ;
Saeian, Kia .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (08) :1719-1725
[2]
[Anonymous], [No title captured]
[3]
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[4]
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome [J].
Barbara, Giovanni ;
Wang, Bingxian ;
Stanghellini, Vincenzo ;
De Giorgio, Roberto ;
Cremon, Cesare ;
Di Nardo, Giovanni ;
Trevisani, Marcello ;
Campi, Barbara ;
Geppetti, Pierangelo ;
Tonini, Marcello ;
Bunnett, Nigel W. ;
Grundy, David ;
Corinaldesi, Roberto .
GASTROENTEROLOGY, 2007, 132 (01) :26-37
[5]
Functional gastrointestinal disorders: psychological, social, and somatic features [J].
Bennett, EJ ;
Piesse, C ;
Palmer, K ;
Badcock, CA ;
Tennant, CC ;
Kellow, JE .
GUT, 1998, 42 (03) :414-420
[6]
[7]
Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders [J].
Camilleri, Michael ;
Bueno, Lionel ;
de Ponti, Fabrizio ;
Fioramonti, Jean ;
Lydiard, R. Bruce ;
Tack, Jan .
GASTROENTEROLOGY, 2006, 130 (05) :1421-1434
[8]
The significant other version of the pain catastrophizing scale (PCS-S): Preliminary validation [J].
Cano, A ;
Leonard, MT ;
Franz, A .
PAIN, 2005, 119 (1-3) :26-37
[9]
How do SSRIs help patients with irritable bowel syndrome? [J].
Creed, F. .
GUT, 2006, 55 (08) :1065-1067
[10]
Creed Francis, 1999, American Journal of Medicine, V107, p74S